Results 91 to 100 of about 6,649,092 (263)
The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis
Helei Hou,* Dantong Sun,* Kewei Liu, Man Jiang, Dong Liu, Jingjuan Zhu, Na Zhou, Jing Cong, Xiaochun ZhangDepartment of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People’s Republic of China*These ...
Hou H+8 more
doaj
Medical errors : Healthcare professionals’ perspective at a tertiary hospital in Kuwait [PDF]
Medical errors are of economic importance and can contribute to serious adverse events for patients. Medical errors refer to preventable events resulting from healthcare interactions, whether these events harm the patient or not.
Ahmed, Zamzam+3 more
core +4 more sources
A Simple Test of Adverse Events and Strategic Timing Theories of Consumer Bankruptcy [PDF]
A test of adverse events and strategic timing theories can be conducted by determining whether some relevant financial decision variables, such as financial benefit from filing for bankruptcy, or debt discharged in bankruptcy are endogenous with the ...
Li Gan, Tarun Sabarwal
core
Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. [PDF]
Because many patients with unresectable basal cell carcinoma (BCC) are aged ≥65 years, this study explores the efficacy and safety of vismodegib in these patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC) in the ERIVANCE BCC
Arron, Sarah+8 more
core +2 more sources
Objective To evaluate rates of serious organ specific immune-related adverse events, general adverse events related to immune activation, and adverse events consistent with musculoskeletal problems for anti-programmed cell death 1 (PD-1) drugs overall ...
S. Baxi+6 more
semanticscholar +1 more source
Post vaccinal temporary sensorineural hearing loss [PDF]
In our systematic research we identified four studies concerning the onset of neurological adverse events following vaccination and two excluding this association.
De Cesare, Donato Pompeo+8 more
core +1 more source
Adverse events of raltegravir and dolutegravir. [PDF]
To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. Prospective cohort study.
Battegay, Manuel+9 more
core +4 more sources
Background Immune checkpoint inhibitors (ICIs) have transformed tumor treatment. However, the risk of pulmonary adverse events (PAEs) associated with ICI combination therapy is still unclear.
Baohui Hong+6 more
doaj +1 more source
Common Terminology Criteria for Adverse Events
Versione, Francesco Grossi
semanticscholar +1 more source